CM Management’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-90,000
| Closed | -$115K | – | 67 |
|
|
2024
Q2 | $115K | Hold |
90,000
| – | – | 0.11% | 63 |
|
|
2024
Q1 | $339K | Hold |
90,000
| – | – | 0.29% | 59 |
|
|
2023
Q4 | $294K | Hold |
90,000
| – | – | 0.24% | 67 |
|
|
2023
Q3 | $295K | Hold |
90,000
| – | – | 0.31% | 56 |
|
|
2023
Q2 | $403K | Hold |
90,000
| – | – | 0.39% | 58 |
|
|
2023
Q1 | $434K | Sell |
90,000
-20,000
| -18% | -$96.4K | 0.52% | 48 |
|
|
2022
Q4 | $344K | Sell |
110,000
-15,000
| -12% | -$46.9K | 0.41% | 56 |
|
|
2022
Q3 | $408K | Hold |
125,000
| – | – | 0.46% | 59 |
|
|
2022
Q2 | $450K | Hold |
125,000
| – | – | 0.48% | 59 |
|
|
2022
Q1 | $511K | Buy |
125,000
+35,000
| +39% | +$143K | 0.43% | 61 |
|
|
2021
Q4 | $489K | Buy |
90,000
+25,673
| +40% | +$139K | 0.37% | 75 |
|
|
2021
Q3 | $479K | Buy |
64,327
+54,327
| +543% | +$405K | 0.36% | 76 |
|
|
2021
Q2 | $100K | Buy |
+10,000
| New | +$100K | 0.07% | 83 |
|